PROVIDER PROFILE · NPI 1669542635

Karole ShaferACNP

Nurse PractitionerNewark, NYI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

342

Unique beneficiaries

—

Total services

370

Distinct HCPCS

Medicare payment

$24K

Peer benchmark

Total Medicare services vs. 10,295 Nurse Practitioner providers in NY — above median (cohort median 188).

PRESCRIBING · PART D · 2024

Total Rx claims

357

Beneficiaries

—

Total drug cost

$3K

Distinct drugs

Brand share

22.1%

Top prescribed drugs

Doxycycline Hyclate75 claims

Prednisone42 claims

Cephalexin35 claims

Albuterol Sulfate34 claims

Methylprednisolone34 claims

QUALITY · MIPS · 2024

Final MIPS score

96.6

Quality

74.5

Cost

0.0

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.91%

APM Entity

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Karole Shafer's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 7 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Daniel Alexander Orthopedic Surgery · Auburn, NY	83	190
ROCHESTER GENERAL HOSPITAL	33	67
CLIFTON SPRINGS SANITARIUM CO	22	53
Gregory Shields Diagnostic Radiology · Buffalo, NY	16	20
James Rinaldi Diagnostic Radiology · Williamsville, NY	14	21
Erin Kearns Physician Assistant · Geneva, NY	13	16
Anthony Dasilva Internal Medicine · Newark, NY	12	35

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history